Screener
Arcutis Biotherapeutics, Inc. ARQT Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 10,939 | 7,492 | 20,723 | 16,322 |
| Research and development | 20,355 | 19,453 | 50,982 | 36,996 |
| Selling, general and administrative | 82,138 | 69,170 | 156,214 | 133,172 |
| Total operating expenses | 113,432 | 96,115 | 227,919 | 186,490 |
| Income (loss) from operations | 16,429 | (14,611) | 7,340 | (39,140) |
| Other income (expense): | ||||
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
| Interest expense | (3,406) | (3,029) | (7,774) | (6,011) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s total costs & expenses?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total costs & expenses of $113.43M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s total costs & expenses changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total costs & expenses increased by 18.0% year-over-year, from $96.12M to $113.43M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s total costs & expenses has grown at a 17.1% compound annual growth rate (CAGR), from $206.53M to $388.3M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the company's total resource consumption to support its business model. Monitoring this figure is essential for assessing operational efficiency and the sustainability of the company's burn rate.
Ask your AI about Arcutis Biotherapeutics, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude